HERPES ZOSTER IN BARICITINIB-TREATED JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS USING REAL-WORLD CLINICAL DATA

被引：0

作者：

Torikai, E. ^{[1
]}

Hirano, Y. ^{[2
]}

Suzuki, D. ^{[3
]}

Kanayama, Y. ^{[4
]}

机构：

[1] Iwata City Hosp, Iwata, Japan

[2] Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan

[3] Futaba Clin, Iwata, Japan

[4] Toyota Kosei Hosp, Toyota, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.3023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0362

引用

页码：1478 / 1478

页数：1

共 4 条

[1]

Fleischmann R, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000546

[2] Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials [J].

Harigai, Masayoshi ;

Takeuchi, Tsutomu ;

Smolen, Josef S. ;

Winthrop, Kevin L. ;

Nishikawa, Atsushi ;

Rooney, Terence P. ;

Saifan, Chadi G. ;

Issa, Maher ;

Isaka, Yoshitaka ;

Akashi, Naotsugu ;

Ishii, Taeko ;

Tanaka, Yoshiya .

MODERN RHEUMATOLOGY, 2020, 30 (01) :36-43

[3] The Pharmacokinetics, Pharmacodynamics, and Safety of Baricitinib, an Oral JAK 1/2 Inhibitor, in Healthy Volunteers [J].

Shi, Jack G. ;

Chen, Xuejun ;

Lee, Fiona ;

Emm, Thomas ;

Scherle, Peggy A. ;

Lo, Yvonne ;

Punwani, Naresh ;

Williams, William V. ;

Yeleswaram, Swamy .

JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (12) :1354-1361

[4] Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis [J].

Taylor, Peter C. ;

Keystone, Edward C. ;

van der Heijde, Desiree ;

Weinblatt, Michael E. ;

del Carmen Morales, Liliana ;

Reyes Gonzaga, Jaime ;

Yakushin, Sergey ;

Ishii, Taeko ;

Emoto, Kahaku ;

Beattie, Scott ;

Arora, Vipin ;

Gaich, Carol ;

Rooney, Terence ;

Schlichting, Douglas ;

Macias, William L. ;

de Bono, Stephanie ;

Tanaka, Yoshiya .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :652-662

← 1 →